Entity

Time filter

Source Type

Daejeon, South Korea

Kang S.H.,Armed Forces Daejeon Hospital | Choi S.-W.,Office of the Surgeon General | Lee S.J.,Kyungpook National University | Chung W.S.,Korea Advanced Institute of Science and Technology | And 7 more authors.
Gut and Liver | Year: 2011

Background/Aims: Although notably common, irritable bowel syndrome (IBS) has no specific cure. Lifestyle modification may be as important as medication; however, few studies support the effectiveness of such modifications. We performed this observational study of IBS patients to explore further the role of lifestyle changes in treatment. Methods: This study included 831 men who enlisted in 2010 as armed surgeon cadets and 85 women who concurrently entered the Armed Forces Nursing Academy. Of these 916 participants, 89 were diagnosed with IBS using the Rome III criteria. Subjective changes in bowel habits, quality of life, pain, stress, stool frequency and stool consistency were surveyed before and after 9 weeks of army training. We evaluated the lifestyle risk factors that impacted improvement in IBS symptoms by comparing those who responded to lifestyle modification (the responding group) to those who did not respond (the nonresponding group). Results: More than half of the participants (63%) reported that their symptoms improved after training. The quality of life and levels of pain and stress significantly improved after military training. Initial stress levels before military training and smoking history affected IBS symptom improvement. Conclusions: Lifestyle modification may be effective in managing IBS patients. Source


Park S.H.,Inje University | Park J.H.,Armed Forces Nursing Academy | Kang J.W.,Inje University | Park H.Y.,Inje University | And 2 more authors.
Journal of Paediatrics and Child Health | Year: 2013

Aim Early identification of the metabolic syndrome (MS) and abnormal lipid levels with subsequent life-style intervention is vital to halt disease progression and safeguard the future health of children and adolescents. Methods Data from a representative sample of 1554 adolescents (821 boys and 733 girls) aged 10-19 from the 2007-2008 Korea National Health and Nutrition Examination Survey was analysed. The MS was defined using the paediatric criteria of the International Diabetes Federation. Abnormal lipid levels were classified according to the guidelines of the American Academy of Pediatrics. Results Approximately 13.7% of adolescents have a body mass index (BMI) between the 85th and 94th percentiles, and 8.4% have a BMI of ≥95th percentile. The prevalence of the MS was 2.3% among all the participants, 2.7% among boys and 2.1% among girls. The prevalence of the MS was 2.8% among overweight adolescents and 23.7% among obese adolescents. A low high-density lipoprotein cholesterol level was the most common component for the MS. Nearly 20% of adolescents (21% of boys and 19% of girls) had at least one lipid abnormality. Approximately 32% of overweight adolescents and 50% of obese adolescents were candidates for therapeutic life-style counselling based on lipid levels. Conclusions The present study provides the most updated prevalence estimates of the MS in the Korean adolescent population and highlights the strong association of the MS with BMI. The prevalence of abnormal lipid levels in overweight and obese adolescents is high, illustrating the large burden of cardiovascular disease in the future Korean population. © 2013 The Authors. Journal of Paediatrics and Child Health © 2013 Paediatrics and Child Health Division (Royal Australasian College of Physicians). Source


Park S.H.,Inje University | Park J.H.,Armed Forces Nursing Academy | Song P.S.,Inje University | Kim D.K.,Inje University | And 10 more authors.
Journal of the American Society of Hypertension | Year: 2013

Low muscle mass has been associated with arterial stiffness. The aim of the study was to determine whether sarcopenic obesity is associated with hypertension. Subjects consisted of 6832 adults who participated in the 2009 Korea National Health and Nutrition Examination Survey. Participants were classified as normal, sarcopenic, obese, or sarcopenic-obese based on the following measures: waist circumference and appendicular skeletal muscle mass divided by weight (ASM/Wt). The sarcopenic-obese group had systolic and diastolic blood pressure levels that were ≈12 mm Hg and 5 mm Hg higher, respectively, than those in the normal group. Compared with the normal group, the odds ratio (OR) of having hypertension for the sarcopenic, obese, and sarcopenic-obese groups were 2.48 (95% confidence interval [CI], 1.89-6.16), 3.15 (95% CI, 2.76-3.59), and 6.42 (95% CI, 4.85-8.48) times higher, respectively. When waist circumference and ASM/Wt were used as continuous variables in the same regression model, ASM/Wt was a significant predictor of hypertension (OR, 0.94; 95% CI, 0.89-0.98). Sarcopenic obesity is associated with hypertension, while low muscle mass is also correlated with hypertension, independent of abdominal obesity. Abdominal obesity and sarcopenia may potentiate each other to induce hypertension. © 2013 American Society of Hypertension. All rights reserved. Source


Park S.H.,Inje University | Park J.H.,Armed Forces Nursing Academy | Park H.Y.,Inje University | Jang H.J.,Inje University | And 5 more authors.
Clinical Nutrition | Year: 2014

Background & aims: It is unclear whether sarcopenia contributes to the prediction of metabolic dysregulations in addition to that predicted by waist circumference. Methods: Subjects consisted of 6832 adult participants in the 2009 Korea National Health and Nutrition Examination Survey, grouped into categories of waist circumference (normal vs. high). Sarcopenia was assessed by appendicular skeletal muscle mass divided by weight. Results: In the normal waist circumference category, the risk of metabolic syndrome was nearly 3.5-fold higher in sarcopenic men (OR, 3.39; 95% CI, 1.67-6.90) than in those without sarcopenia. For the high waist circumference category, the risk of metabolic syndrome was 2.5-fold higher in sarcopenic women (OR, 2.37; 95% CI, 1.66-3.40) than in those without sarcopenia. The corresponding risk was also higher in sarcopenic men (OR, 1.81; 95% CI, 1.11-2.94) than in those without sarcopenia. With the exception in men with high waist circumference category, adjustments for other potential confounders did not substantially affect the results. Appendicular skeletal muscle mass divided by weight as a continuous variable was also associated with metabolic syndrome in men (OR, 0.39; 95% CI, 0.35-0.44) and women (OR, 0.53; 95% CI, 0.48-0.60). Conclusions: Sarcopenia is associated with metabolic syndrome in men with normal waist circumference and women with high waist circumference. Our results emphasize that sarcopenia may contribute additionally to the risk of metabolic abnormalities beyond what is predicted by the abdominal obesity category. © 2013 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. Source

Discover hidden collaborations